TD Cowen Maintains a Buy Rating on Zebra Technologies Corporation (ZBRA) stock with a PT of $400.00 - Insider Monkey
π TD Cowen analyst Joseph C Giordano maintains a 'Buy' rating on Zebra Technologies (ZBRA) with a price target of $400.00.
π° Analysts cite management's realistic outlook and sustained demand/pricing power as key drivers supporting higher estimates.
π‘οΈ The company is proactively securing components early to mitigate risks from elevated input costs, pricing pressure, and memory volatility.
π Zebra Technologies' updated 2026 guidance demonstrates rapid growth even under conservative assumptions.
π¦ Morgan Stanley lifted its price objective on ZBRA to $323 from $309 while keeping an 'Equal Weight' rating.
π Analysts believe the company's outlook suggests a reacceleration in performance for 2026.
π Zebra designs hardware, software, and automation solutions serving retail, healthcare, manufacturing, and logistics sectors.
βοΈ Some analysts compare ZBRA to other AI stocks, suggesting alternative opportunities may offer higher upside potential.
- TD Cowen maintains a 'Buy' rating with a $400 price target, indicating strong confidence in the stock's near-term prospects.
- Management's realistic outlook and ability to secure components early demonstrate effective cost management strategies.
- Updated 2026 guidance shows rapid growth even on a conservative side, suggesting robust underlying business performance.
- Morgan Stanley increased its price target to $323, signaling a positive shift in analyst consensus regarding the company's trajectory.
- Analysts note that the current share price does not fully discount the value of ZBRA's rapid 2026 growth projections.
- The article mentions risks including pricing pressure and elevated memory costs which could impact margins if not managed effectively.
- Some analysts suggest that other AI stocks may hold greater promise for delivering higher returns, implying relative underperformance compared to peers.
- Negative market sentiments are currently present, which may be weighing on the stock despite fundamental improvements.